TherapeuticsMD TXMD
NASDAQ TXMD
$1.90 +0.02 (+1.06%)
At close: Oct 21, 2026 · 4:00 PM EDT

TherapeuticsMD (TXMD) Dividends payables (2010 - 2013)

Updated

TherapeuticsMD (TXMD) recorded Dividends payables of $41,359 in Q3 2013, unchanged from the prior quarter.

Analysis

TherapeuticsMD (TXMD) Dividends payables (2010 - 2013) Analysis & Trends

Starting with Q4 2010, TherapeuticsMD's Dividends payables history includes 6 quarters.

  • Across earlier years, Dividends payables came in at $41,359 in FY2010.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dividends payables (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn -
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn -
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn -
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 2.13 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn -
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn -
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn -
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 2.45 Bn
10 TherapeuticsMD 21.67 Mn 21.67 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2013 41,359.00
Jun 30, 2013 41,359.00
Dec 31, 2012 41,359.00
Sep 30, 2011 41,359.00
Jun 30, 2011 41,359.00
Dec 31, 2010 41,359.00
API Access

TherapeuticsMD Dividends payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=dividends-payables&ticker=TXMD&period=max&api_key=YOUR_API_KEY